Karyopharm Therapeutics Inc. (KPTI)
NASDAQ·Healthcare·Biotechnology
$9.60
+5.44%
Mkt Cap $73.93M
Analyst Ratings
Buy
6
Hold
0
Sell
0
Price Target (13 analysts)
$17.25
Range $12.00 – $28.00
Implied Upside
+79.8%
Consensus $17.25 vs current $9.60
NASDAQ·Healthcare·Biotechnology
$9.60
+5.44%
Mkt Cap $73.93M
Buy
6
Hold
0
Sell
0
Price Target (13 analysts)
$17.25
Range $12.00 – $28.00
+79.8%
Consensus $17.25 vs current $9.60